Presented
by

Presented by Oxford Global

Member Login
|
Become a Member

All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Written Q&A
Challenges & Developments of Biosimilars
Steinar Madsen, Medical Director, Norwegian Medicines Agency
24 April 2019
Biosimilars & Biobetters
Written Q&A
Safety in Biosimilars
Uwe Gudat, Head Of Safety, Merck Serono
24 April 2019
Biosimilars & Biobetters
Insight Article
About to Commercialise your Invention? Stop! Do You Have Freedom to Operate?
Dr. Philip Webber, Patent Attorney, Dehns Patent and Trade Mark Attorneys
16 April 2018
Biosimilars & Biobetters
Video Content
Video Q&A
Issues Faced by the Biosimilars Industry & Future Challenges Researchers are Facing in this Field
Principal, Pharmaceutical Law Group PC, Director, Regulatory Affairs, PharmaLex UK
16 April 2018
Biosimilars & Biobetters
Insight Article
Market Exclusivity Issues for Biologics and Biosimilars
Gregory J. Glover, Attorney at Law, Pharmaceutical Law Group PC
16 April 2018
Biosimilars & Biobetters
Written Q&A
Biosuperiors & Biobetter Biologics
Rakesh Dixit, Vice President, R&D, Medimmune
20 April 2015
Biosimilars & Biobetters
Written Q&A
FDA & EMA Regulations in Biosimilars
Mershid Alai-Safar, Senior Director, Regulatory Affairs, Baxter
20 April 2015
Biosimilars & Biobetters

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login